Verena Lieb

480 total citations
31 papers, 290 citations indexed

About

Verena Lieb is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Verena Lieb has authored 31 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Verena Lieb's work include Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Verena Lieb is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Verena Lieb collaborates with scholars based in Germany, United States and Austria. Verena Lieb's co-authors include Bernd Wullich, Sven Wach, Helge Täubert, Arndt Hartmann, Rudolf Jung, Frank Kunath, Danijel Sikic, Robert Stöhr, Markus Eckstein and Mariona Pinart and has published in prestigious journals such as Cancer Research, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

Verena Lieb

30 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Lieb Germany 11 118 93 82 68 43 31 290
Mingxing Qiu China 11 158 1.3× 123 1.3× 75 0.9× 38 0.6× 61 1.4× 29 362
Mutsushi Yamasaki Japan 11 190 1.6× 106 1.1× 97 1.2× 89 1.3× 77 1.8× 29 414
Pengcheng Luo China 12 152 1.3× 77 0.8× 82 1.0× 70 1.0× 37 0.9× 26 351
Haifeng Wang China 10 153 1.3× 62 0.7× 127 1.5× 53 0.8× 98 2.3× 43 357
Chengjian Ji China 13 173 1.5× 116 1.2× 98 1.2× 72 1.1× 48 1.1× 38 367
Guangcheng Dai China 12 185 1.6× 108 1.2× 155 1.9× 24 0.4× 44 1.0× 31 376
Hangchuan Shi United States 12 299 2.5× 213 2.3× 118 1.4× 54 0.8× 56 1.3× 24 477
Yuki Oda Japan 11 218 1.8× 163 1.8× 41 0.5× 67 1.0× 81 1.9× 31 380
Xiaomei Liu China 10 146 1.2× 60 0.6× 55 0.7× 50 0.7× 44 1.0× 35 328
Zhongyuan Zhang China 10 199 1.7× 139 1.5× 114 1.4× 50 0.7× 77 1.8× 20 382

Countries citing papers authored by Verena Lieb

Since Specialization
Citations

This map shows the geographic impact of Verena Lieb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Lieb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Lieb more than expected).

Fields of papers citing papers by Verena Lieb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Lieb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Lieb. The network helps show where Verena Lieb may publish in the future.

Co-authorship network of co-authors of Verena Lieb

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Lieb. A scholar is included among the top collaborators of Verena Lieb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Lieb. Verena Lieb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hart, Martin, Achim Aigner, Florian Handle, et al.. (2025). The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer. Scientific Reports. 15(1). 10272–10272. 1 indexed citations
2.
Eckstein, Markus, Rudolf Jung, Verena Lieb, et al.. (2024). Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients. International Journal of Molecular Sciences. 25(12). 6325–6325. 3 indexed citations
3.
Lieb, Verena, Siegfried Hauch, Michael Gombert, et al.. (2022). Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients. Cells. 11(22). 3618–3618. 1 indexed citations
4.
Serrero, Ginette, Binbin Yue, Robert Stöhr, et al.. (2022). Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients. Life. 12(5). 732–732. 1 indexed citations
5.
Sailer, Verena, Gunhild von Amsberg, Stefan Duensing, et al.. (2022). Experimental in vitro, ex vivo and in vivo models in prostate cancer research. Nature Reviews Urology. 20(3). 158–178. 31 indexed citations
6.
Lieb, Verena, et al.. (2022). Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction. Urologia Internationalis. 106(10). 1041–1049. 7 indexed citations
7.
Eckstein, Markus, Verena Lieb, Rudolf Jung, et al.. (2021). Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients. Cells. 10(7). 1796–1796. 3 indexed citations
8.
Lieb, Verena, Siegfried Hauch, Michael Gombert, et al.. (2021). Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. Cells. 10(11). 3223–3223. 3 indexed citations
9.
Hardenberg, Jost von, Angelika Borkowetz, Fabian Siegel, et al.. (2020). Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Large Multicenter Cohort Study. European Urology Focus. 7(5). 1002–1010. 10 indexed citations
10.
König, Paul, Markus Eckstein, Rudolf Jung, et al.. (2020). Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 12(9). 2639–2639. 5 indexed citations
11.
Eckstein, Markus, Rudolf Jung, Ginette Serrero, et al.. (2019). Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 11(12). 2029–2029. 9 indexed citations
12.
Eckstein, Markus, Verena Sailer, Boye Schnack Nielsen, et al.. (2019). Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays. Laboratory Investigation. 99(10). 1527–1534. 13 indexed citations
13.
Tsaur, Igor, Tanja Hüsch, Meike Schneider, et al.. (2019). sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro. Urologic Oncology Seminars and Original Investigations. 37(6). 355.e1–355.e9. 1 indexed citations
14.
Pinart, Mariona, Frank Kunath, Verena Lieb, et al.. (2018). Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review. World Journal of Urology. 38(3). 613–635. 19 indexed citations
15.
Eckstein, Markus, Rudolf Jung, Danijel Sikic, et al.. (2018). Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients. Scientific Reports. 8(1). 17693–17693. 16 indexed citations
16.
Wach, Sven, Bernhard Michalke, Verena Lieb, et al.. (2017). Diagnostic potential of major and trace elements in the serum of bladder cancer patients. Journal of Trace Elements in Medicine and Biology. 46. 150–155. 21 indexed citations
17.
Bertz, Simone, Elke Nolte, Christine Stöhr, et al.. (2017). Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma. Scientific Reports. 7(1). 16424–16424. 6 indexed citations
18.
Stoehr, Robert, Antonia Wenners, Arndt Hartmann, et al.. (2016). Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients. Oncogenesis. 5(2). e205–e205. 3 indexed citations
19.
Lieb, Verena, Michael Rink, Danijel Sikic, & Bastian Keck. (2016). Nebenwirkungsmanagement von Tyrosinkinaseinhibitoren in der Urologie. Der Urologe. 55(6). 805–812. 1 indexed citations
20.
Sikic, Danijel, Sven Wach, Helge Täubert, et al.. (2016). How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience. Urologia Internationalis. 98(3). 262–267. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingxing Qiu Breakdown of academic impact, for papers by Mutsushi Yamasaki Breakdown of academic impact, for papers by Pengcheng Luo Breakdown of academic impact, for papers by Haifeng Wang Breakdown of academic impact, for papers by Chengjian Ji Breakdown of academic impact, for papers by Guangcheng Dai Breakdown of academic impact, for papers by Hangchuan Shi Breakdown of academic impact, for papers by Yuki Oda Breakdown of academic impact, for papers by Xiaomei Liu Breakdown of academic impact, for papers by Zhongyuan Zhang
Rankless by CCL
2026